This page lists the SEC filings reported by HHLR ADVISORS, LTD..
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-14 | HHLR ADVISORS, LTD. | Agora, Inc. | 19,287,300 | 5.1% | EDGAR |
SC 13G/A | 2024-02-14 | HHLR ADVISORS, LTD. | Bright Scholar Education Holdings Ltd | 3,952,572 | 12.6% | EDGAR |
SC 13G/A | 2024-02-14 | HHLR ADVISORS, LTD. | MOGU Inc. | 254,253,005 | 11.8% | EDGAR |
SC 13G/A | 2024-02-14 | HHLR ADVISORS, LTD. | Aligos Therapeutics, Inc. | 5,971,426 | 8.2% | EDGAR |
SC 13G/A | 2024-02-14 | HHLR ADVISORS, LTD. | Cytek Biosciences, Inc. | 6,657,030 | 4.9% | EDGAR |
SC 13G/A | 2024-02-14 | HHLR ADVISORS, LTD. | Kiniksa Pharmaceuticals, Ltd. | 3,879,426 | 9.9% | EDGAR |
SC 13G/A | 2024-02-14 | HHLR ADVISORS, LTD. | Smart Share Global Ltd | 62,367,293 | 14.0% | EDGAR |
SC 13G/A | 2023-08-18 | HHLR ADVISORS, LTD. | Kiniksa Pharmaceuticals, Ltd. | 3,541,301 | 9.9% | EDGAR |
SC 13D/A | 2023-06-30 | HHLR ADVISORS, LTD. | I-Mab | 15,891,211 | 8.3% | EDGAR |
SC 13D/A | 2023-02-14 | HHLR ADVISORS, LTD. | BeiGene, Ltd. | 147,043,058 | 10.9% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | Yatsen Holding Ltd | 300,560,602 | 19.1% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | Bright Scholar Education Holdings Ltd | 3,985,796 | 15.6% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | MOGU Inc. | 261,174,005 | 11.9% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | Kiniksa Pharmaceuticals, Ltd. | 2,623,924 | 7.6% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | Gossamer Bio, Inc. | 4,974,041 | 5.3% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | Cytek Biosciences, Inc. | 8,684,530 | 6.4% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | Aligos Therapeutics, Inc. | 2,309,764 | 5.8% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | Root, Inc. | 138,977 | 1.5% | EDGAR |
SC 13G/A | 2023-02-14 | HHLR ADVISORS, LTD. | On Holding AG | 5,468,504 | 1.9% | EDGAR |
SC 13D/A | 2022-08-16 | HHLR ADVISORS, LTD. | BeiGene, Ltd. | 147,035,258 | 10.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.